Patrick Rizk1, Mario Rodenas2, Anna De Benedetto3. 1. Department of Dermatology, College of Medicine University of Florida, 4037 NW 86 Terrace, Gainesville, FL, 32606, USA. 2. Section of Allergy and Clinical Immunology, Division of Rheumatology, Department of Medicine, College of Medicine University of Florida, Gainesville, FL, USA. 3. Department of Dermatology, College of Medicine University of Florida, 4037 NW 86 Terrace, Gainesville, FL, 32606, USA. adebenedetto@ufl.edu.
Abstract
PURPOSE OF REVIEW: In light of the recent advancements in atopic dermatitis treatment, this review aims to summarize the utility and efficacy of allergy immunotherapy in atopic dermatitis patients. We examine its mechanism, pathophysiology, cost-efficacy, and current guidelines for clinical practice. RECENT FINDINGS: The literature supports the use of allergy immunotherapy in atopic conditions such as allergic rhinitis and asthma but insufficient evidence exists to suggest its efficacy in atopic dermatitis. The use of allergy immunotherapy has been shown to provide long-term cost savings in both the USA and the European Union in certain populations but differences in prescribing patterns and manufacturing make it difficult to study its impact on a larger, generalizable scale. Conflicting meta-analyses data and conclusions highlight the need for better, higher quality research to better understand allergy immunotherapy utility in atopic dermatitis.
PURPOSE OF REVIEW: In light of the recent advancements in atopic dermatitis treatment, this review aims to summarize the utility and efficacy of allergy immunotherapy in atopic dermatitispatients. We examine its mechanism, pathophysiology, cost-efficacy, and current guidelines for clinical practice. RECENT FINDINGS: The literature supports the use of allergy immunotherapy in atopic conditions such as allergic rhinitis and asthma but insufficient evidence exists to suggest its efficacy in atopic dermatitis. The use of allergy immunotherapy has been shown to provide long-term cost savings in both the USA and the European Union in certain populations but differences in prescribing patterns and manufacturing make it difficult to study its impact on a larger, generalizable scale. Conflicting meta-analyses data and conclusions highlight the need for better, higher quality research to better understand allergy immunotherapy utility in atopic dermatitis.
Entities:
Keywords:
AIT efficacy; Allergy immunotherapy; Atopic dermatitis; Treatment
Authors: C Uermösi; F Zabel; V Manolova; M Bauer; R R Beerli; G Senti; T M Kündig; P Saudan; M F Bachmann Journal: Allergy Date: 2013-12-19 Impact factor: 13.146
Authors: A Wollenberg; S Barbarot; T Bieber; S Christen-Zaech; M Deleuran; A Fink-Wagner; U Gieler; G Girolomoni; S Lau; A Muraro; M Czarnecka-Operacz; T Schäfer; P Schmid-Grendelmeier; D Simon; Z Szalai; J C Szepietowski; A Taïeb; A Torrelo; T Werfel; J Ring Journal: J Eur Acad Dermatol Venereol Date: 2018-06 Impact factor: 6.166
Authors: J Ring; A Zink; B W M Arents; I A Seitz; U Mensing; M C Schielein; N Wettemann; G de Carlo; A Fink-Wagner Journal: J Eur Acad Dermatol Venereol Date: 2019-06-06 Impact factor: 6.166
Authors: Katharina Rindler; Thomas Krausgruber; Felix M Thaler; Natalia Alkon; Christine Bangert; Harald Kurz; Nikolaus Fortelny; Thomas B Rojahn; Constanze Jonak; Johannes Griss; Christoph Bock; Patrick M Brunner Journal: Front Immunol Date: 2021-02-24 Impact factor: 7.561